Shares & shareholders

Live Share information

Since opening
Since yesterday
Dernier cours
Opening
Highest
Lower
Previous closing

Nombre de titres échangés
Exchanged capital
Capitalization
52 weeks [low/high]
€ /
Performances (%)
A week
%
A month
%
3 months
%
Since January 1
%
A year
%

Share ID

date of IPO:
04-02-2014
Code ISIN / Mnemo / Reuters / Bloomberg :
/ ALONC / ALONC.PA / ALONC:FP
Listed on:
Euronext Growth Paris
Financial year closing date:
December 31
Number of shares:
Nominal value:
Liquidity provider:
Louis Capital Markets
Listing sponsor :
Midcap Partners
Qualification « Entreprise innovante » pour les FCPI :
Eligible PEA-PME
This website contains data provided by Euronext. This data is provided "as is" for information purposes only without any guarantees. Although all reasonable precautions have been taken to ensure the accuracy of the data, Euronext does not guarantee accuracy or completeness. Oncodesign cannot be held responsible for the use of these data. This information cannot be considered as creating rights or commitments from Oncodesign or any representative company.

Shareholding

A true entrepreneurial project and a rare occurrence in biotechnology, Oncodesign’s capital is mainly held by its managers, including Dr. Philippe Genne, CEO and Founder of the company. The interests of management and shareholders remain perfectly aligned.

General Meetings

Repartition-capital-S2-2020 - charté-EN

Consolidated key figures

Key figures

€ millionsFY20FY19FY18FY17
Turnover Other operating income25.5 13.026.9 12.620.1 12.714.3 11.6
Total operating income Total costs38.5 (37.0)39.5 (38.8)32.8 (36.6)25.9 (30.3)
Operating income Financial expenses and income Exceptional expenses and income Income tax Amortization of negative goodwill1.5 (0.6) (0.2) 0.4 1.00.7 (0.2) (0.1) 0.3 1.0(3.8) (0.3) 0.1 (0.0) 0.8(4.4) (0.2) (1.2) (0.3) 1.0
net Consolidated Income / Loss2.11.6(3.1)(5.0)
Investments in R&D10.811.112.013.9
Cash position at 31.12.N28.710.510.111.5
Staff238233232180

Change

19/2018/1917/18
-5% 3%34% -1%41% 9%
-2% -5%20% 6%27% 21%
+0.8M€ ns 62%+4.5M€ ns 25%+0.6M€ ns -20%
+0.5M€+4.8M€+1.8M€
-3%-8%-14%
+18.2M€+0.5M€+1.4M€

Last updated: 2020
These key figures are updated according to the financial calendar